Cysticercosis (Pork Tapeworm Infection) Differential Diagnoses

1. Schantz PM, Moore AC, Muñoz JL, Hartman BJ, Schaefer JA, Aron AM, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med. 1992 Sep 3. 327(10):692-5. [QxMD MEDLINE Link].

2. White AC Jr, Garcia HH. Updates on the management of neurocysticercosis. Curr Opin Infect Dis. 2018 Oct. 31 (5):377-382. [QxMD MEDLINE Link].

3. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg Infect Dis. 2007 Feb. 13(2):230-5. [QxMD MEDLINE Link].

4. Wu W, Qian X, Huang Y, Hong Q. A review of the control of clonorchiasis sinensis and Taenia solium taeniasis/cysticercosis in China. Parasitol Res. 2012 Oct 5. [QxMD MEDLINE Link].

5. de Bittencourt PR, Adamolekum B, Bharucha N, et al. Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia. 1996 Nov. 37(11):1121-7. [QxMD MEDLINE Link].

6. Ng-Nguyen D, Stevenson MA, Traub RJ. A systematic review of taeniasis, cysticercosis and trichinellosis in Vietnam. Parasit Vectors. 2017 Mar 21. 10 (1):150. [QxMD MEDLINE Link].

7. Trevisan C, Sotiraki S, Laranjo-González M, Dermauw V, Wang Z, Kärssin A, et al. Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe. Parasit Vectors. 2018 Oct 30. 11 (1):569. [QxMD MEDLINE Link].

8. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004 Nov 9. 63(9):1559-64. [QxMD MEDLINE Link].

9. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002 Jun. 8(6):608-13. [QxMD MEDLINE Link].

10. O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis. 2015 Jun. 21 (6):969-76. [QxMD MEDLINE Link].

11. Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis. 1999 Nov. 29(5):1203-9. [QxMD MEDLINE Link].

12. Malik AM, Shamim MD, Ahmad M, Abdali N. Neurocysticercosis presenting as focal hydrocephalus. BMJ Case Rep. 2014 Jun 24. 2014:[QxMD MEDLINE Link].

13. Prasad R, Shambhavi, Mishra OP, Upadhyay SK, Singh TB, Singh UK. Cognitive and Behaviour Dysfunction of Children with Neurocysticercosis: A Cross-Sectional Study. J Trop Pediatr. 2014 Jun 13. [QxMD MEDLINE Link].

14. Belizario V Jr, Delos Trinos JP, Garcia NB, Reyes M. Cutaneous Manifestations of Selected Parasitic Infections in Western Pacific and Southeast Asian Regions. Curr Infect Dis Rep. 2016 Sep. 18 (9):30. [QxMD MEDLINE Link].

15. Othman AA, Bruschi F, Ganna AA. Helminth parasitic infections of the central nervous system: a diagnostic approach. J Egypt Soc Parasitol. 2014 Apr. 44(1):55-70. [QxMD MEDLINE Link].

16. Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2016 Nov 21. 372:202-210. [QxMD MEDLINE Link]. [Full Text].

17. Fleury A, Hernandez M, Fragoso G, et al. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg. 2003 Sep-Oct. 97(5):542-6. [QxMD MEDLINE Link].

18. Cardona-Arias JA, Carrasquilla-Agudelo YE, Restrepo-Posada DC. [Validity of three methods for inmuno-diagnostic of neurocysticercosis: systematic review of the literature with meta-analysis 1960-2014]. Rev Chilena Infectol. 2017 Feb. 34 (1):33-44. [QxMD MEDLINE Link].

19. Wu HW, Ito A, Ai L, Zhou XN, Acosta LP, Lee Willingham A III. Cysticercosis/taeniasis endemicity in Southeast Asia: Current status and control measures. Acta Trop. 2017 Jan. 165:121-132. [QxMD MEDLINE Link].

20. White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018 Apr 3. 66 (8):e49-e75. [QxMD MEDLINE Link].

21. Cavellani CL, Corrêa RR, Ferraz ML, Rocha LP, Faleiros AC, Lino Junior Rde S, et al. Influence of gender on cardiac and encephalic inflammation in the elderly with cysticercosis: a case control study. J Trop Med. 2012. 2012:540858. [QxMD MEDLINE Link]. [Full Text].

22. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997. 66:209-30. [QxMD MEDLINE Link].

23. Del Brutto OH, Sotelo J, Roman GC. Neurocysticercosis: a clinical handbook. Lisse, The Netherlands: Swets and Zeitlinger; 1998.

24. Sotelo J, Rosas N, Palencia G. Freezing of infested pork muscle kills cysticerci. JAMA. 1986 Aug 15. 256 (7):893-4. [QxMD MEDLINE Link].

25. Garcia HH, Gonzalez AE, Tsang VC, O'Neal SE, Llanos-Zavalaga F, Gonzalvez G, et al. Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med. 2016 Jun 16. 374 (24):2335-44. [QxMD MEDLINE Link].

26. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [QxMD MEDLINE Link].

27. Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014 Aug. 14(8):687-95. [QxMD MEDLINE Link].

28. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001 Jul 24. 57(2):177-83. [QxMD MEDLINE Link].

29. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [QxMD MEDLINE Link].

30. Kelley R, Duong DH, Locke GE. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery. 2002 Apr. 50(4):757-61; discussion 761-2. [QxMD MEDLINE Link].

31. Del Brutto OH, Castillo PR, Mena IX, et al. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol. 1997 Sep. 54(9):1125-8. [QxMD MEDLINE Link].

32. Del Brutto OH. Neurocysticercosis. Semin Neurol. 2005 Sep. 25(3):243-51. [QxMD MEDLINE Link].

33. Del Brutto OH, Santibanez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992 Feb. 42(2):389-92. [QxMD MEDLINE Link].

34. Garcia HH, Gilman RH, Tovar MA, et al. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg. 1995 Feb. 52(2):145-8. [QxMD MEDLINE Link].

35. García HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003 Jun. 87(1):71-8. [QxMD MEDLINE Link].

36. [Guideline] García HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002 Oct. 15(4):747-56. [QxMD MEDLINE Link].

37. Gordon E, Cartwright M, Avasarala J. Ventricular obstruction from neurocysticercosis. Arch Neurol. 2005 Jun. 62(6):1018. [QxMD MEDLINE Link].

38. Gravori T, Steineke T, Bergsneider M. Endoscopic removal of cisternal neurocysticercal cysts. Technical note. Neurosurg Focus. 2002 Jun 15. 12(6):e7. [QxMD MEDLINE Link].

39. Immunetics, Inc. Qualicode Cysticecosis Western Blot Kit. 1997. [Full Text].

40. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician. 2007 Jul 1. 76(1):91-6. [QxMD MEDLINE Link].

41. Nainiwal S, Chand M, Verma L, et al. Intraocular live cysticercus larva. Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec. 34(6):464-6. [QxMD MEDLINE Link].

42. Ramakrishnan P, Bahirwani S, Balaji P. Cysticercosis of the masseter. Indian J Dent Res. 2012 May. 23(3):436. [QxMD MEDLINE Link].

43. Salinas R, Counsell C, Prasad K, et al. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials. Trop Med Int Health. 1999 Nov. 4(11):713-8. [QxMD MEDLINE Link].

44. Sharma T, Sinha S, Shah N, et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003 May. 110(5):996-1004. [QxMD MEDLINE Link].

45. Sotelo J, Escobedo F, Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. 1988 May. 45(5):532-4. [QxMD MEDLINE Link].

46. Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit. 2004 Dec. 23(4):255-62. [QxMD MEDLINE Link].

47. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis. 1997 Feb. 24(2):101-13; quiz 114-5. [QxMD MEDLINE Link].

48. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997. 66:209-30. [QxMD MEDLINE Link].

49. Gripper LB, Welburn SC. The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review. Infect Dis Poverty. 2017 Apr 5. 6 (1):31. [QxMD MEDLINE Link].

50. Donadeu M, Fahrion AS, Olliaro PL, Abela-Ridder B. Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. PLoS Negl Trop Dis. 2017 Sep. 11 (9):e0005875. [QxMD MEDLINE Link].

Joseph Adrian L Buensalido, MD Clinical Associate Professor, Division of Infectious Diseases, Department of Medicine, Philippine General Hospital, University of the Philippines Manila College of Medicine; Specialist in Infectious Diseases, Private Practice

Joseph Adrian L Buensalido, MD is a member of the following medical societies: American Society for Microbiology, Infectious Diseases Society of America, Michigan Infectious Disease Society, Philippine College of Physicians, Philippine Medical Association, Philippine Society for Microbiology and Infectious Diseases

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Unilab; BSV Bioscience; Philcare Pharma<br/>Received sponsorship to medical conference for: Pfizer; Natrapharm.

Kingbherly L Li, MD, RMT, FPCP, FPSMID Active Staff, Section of Infectious Diseases, Department of Internal Medicine, Chair, Hospital Infection Control Committee, Chinese General Hospital and Medical Center; Assistant Professor, Section of Infectious Diseases, College of Medicine, Chinese General Hospital Colleges, Philippines

Kingbherly L Li, MD, RMT, FPCP, FPSMID is a member of the following medical societies: Manila Medical Society, Philippine College of Physicians, Philippine Medical Association, Philippine Society for Microbiology and Infectious Diseases

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Pfizer; BSV BioScience.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

John W King, MD Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University School of Medicine in Shreveport; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center

John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Association of Subspecialty Professors, Infectious Diseases Society of America, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Pranatharthi Haran Chandrasekar, MBBS, MD Professor, Chief of Infectious Disease, Department of Internal Medicine, Wayne State University School of Medicine

Pranatharthi Haran Chandrasekar, MBBS, MD is a member of the following medical societies: American College of Physicians, American Society for Microbiology, International Immunocompromised Host Society, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

David Hall Shepp, MD Program Director, Fellowship in Infectious Diseases, Department of Medicine, North Shore University Hospital; Associate Professor, New York University School of Medicine

David Hall Shepp, MD is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Received salary from Gilead Sciences for management position.

Martin Montes, MD Fellow, Department of Medicine, Section of Infectious Disease, Baylor College of Medicine; Research Associate, Instituto de Medicina Tropical ‘Alexander von Humboldt’, Universidad Peruana Cayetano Heredia, Perú

Disclosure: Nothing to disclose.

Linda S Yancey, MD Consulting Staff, West Houston Infectious Diseases

Linda S Yancey, MD is a member of the following medical societies: American College of Physicians, American Medical Association, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Mossammat M Mansur, MD, MBBS Attending Physician, Nassau ID Physicians

Mossammat M Mansur, MD, MBBS is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Nothing to disclose.

The authors and editors would like to acknowledge Dr. Martin Montes, Dr. Clinton White Jr., and Dr. Thomas P. Giordano, who were the original authors of this article. They would also like to acknowledge the prior contributions of Dr. John W King to the development and writing of this article.

What would you like to print?

• Print this section
• Print the entire contents of
• Print the entire contents of article